MENU
+Compare
RICFY
Stock ticker: OTC
AS OF
Feb 3 closing price
Price
$13.64
Change
-$1.40 (-9.31%)
Capitalization
11.27B

RICFY Recordati Industria Chimica e Farmaceutica S.p.A. Forecast, Technical & Fundamental Analysis

Recordati SpA is a drug manufacturing company that focuses on specialty pharmaceuticals... Show more

RICFY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for RICFY with price predictions
Feb 03, 2026

RICFY's RSI Indicator descends into oversold zone

The RSI Oscillator for RICFY moved into overbought territory on February 03, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 20 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Aroon Indicator entered an Uptrend today. In of 85 cases where RICFY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on February 03, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on RICFY as a result. In of 45 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for RICFY turned negative on February 03, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 23 similar instances when the indicator turned negative. In of the 23 cases the stock turned lower in the days that followed. This puts the odds of success at .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.900) is normal, around the industry mean (9.409). P/E Ratio (23.912) is within average values for comparable stocks, (24.389). Projected Growth (PEG Ratio) (1.092) is also within normal values, averaging (1.865). Dividend Yield (0.027) settles around the average of (0.025) among similar stocks. P/S Ratio (3.785) is also within normal values, averaging (3.952).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. RICFY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RICFY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 72, placing this stock worse than average.

View a ticker or compare two or three
RICFY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published Dividends

RICFY paid dividends on June 05, 2025

Recordati Industria Chimica e Farmaceutica S.p.A. RICFY Stock Dividends
А dividend of $0.19 per share was paid with a record date of June 05, 2025, and an ex-dividend date of May 20, 2025. Read more...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
N/A
Address
Via Matteo Civitali 1
Phone
+39 2487871
Employees
4369
Web
https://www.recordati.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TPHD41.130.58
+1.43%
Timothy Plan High Dividend Stock ETF
MYCI25.00N/A
N/A
State Street® My2029 Corporate Bond ETF
FCOM74.16-1.05
-1.40%
Fidelity MSCI Communication ServicesETF
TUGN24.99-0.40
-1.56%
STF Tactical Growth & Income ETF
XYZG10.89-1.52
-12.22%
Leverage Shares 2X Long XYZ Daily ETF

Groups containing RICFY

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RICFY
1D Price
Change %
RICFY100%
-4.28%
Pharmaceuticals: Major
industry (59 stocks)
17%
Poorly correlated
+0.43%
Pharmaceuticals
industry (380 stocks)
14%
Poorly correlated
-0.30%